Direktorat Registrasi ObatValid

CEFTAZIDIME PENTAHYDRATE

BPOM Number: GKL1513708744A1
Approved: 14 July 2026
Expiry: 13 June 2031
Form: SERBUK INJEKSI

About This Registration

CEFTAZIDIME PENTAHYDRATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL1513708744A1. Its current registration status is Valid, with the licence valid until 13 June 2031. The product is registered to MAHAKAM BETA FARMA - INDONESIA. BPOM first approved this registration in July 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration data updated by BPOM

This product's registration details were changed on 15 July 2026. This may reflect a status change, renewal, or correction by BPOM.

Registration Details

Application: newaero
Packaging: DUS, 10 VIAL @ 1 G
Department: Direktorat Registrasi Obat
Data Last Updated: 15 July 2026

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

MAHAKAM BETA FARMA - INDONESIA
KODYA JAKARTA TIMUR
NPWP: 12345678910
owner
View profile →

Manufacturing Sites

MAHAKAM BETA FARMA - INDONESIA
KODYA JAKARTA TIMUR
primary
View profile →

Ingredients (1)

KOMBINASI-CEFTAZIDIME PENTAHYDRATE WITH SODIUM CARBONATE

Market Intelligence

Owner Portfolio: MAHAKAM BETA FARMA - INDONESIA holds 151 BPOM registrations
Manufacturer Scale: MAHAKAM BETA FARMA - INDONESIA produces 151 registered products
Registration Age: Registered for 1 month
Update Status: Recently updated (49 days ago)

FDA Cross-Reference

via openFDA

Generic Name: CEFTAZIDIME
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: INTRAMUSCULAR

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?